• Print
  • Share
close

Share this on...

Share this site with others using one of these sharing tools.

 

Link to this article

To link to this article, paste this block of HTML code onto your webpage.

Guidelines for sites linking to mayoclinic.org

Atrial Fibrillation

Clinical Trials

Below is a list of Atrial Fibrillation clinical trials from the clinical trials database at Mayo Clinic.

Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

Atrial Fibrillation Recurrence in Sleep Apnea
sleep apnea is a common disorder which is increasingly implicated in the pathogenesis of cardiovascular disease. Observational data suggest that sleep apnea may play a role in the development of atrial fibrillation (AF), and may even predispose to recurrence of AF following electrical cardioversion (DCCV).
Read more

Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
The need for this trial arises out of 1) the rapidly increasing number of pts > 60 years of age with AF accompanied by symptoms and morbidity, 2) the failure of anti-arrhythmic drug therapy to maintain sinus rhythm and reduce mortality, 3) the rapidly increasing application of radio-frequency catheter ablation without appropriate evidence-based validation, and 4) the expanding impact of AF on health care
Read more

Effectiveness of an Investigational Medicine in Patients with Atrial Fibrillation/Atrial Flutter
This study is being done to test the effects of an investigational medicine in patients with Atrial Fibrillation/Atrial Flutter. The study will see if this medication can prevent death or cardiovascular hospitalization.
Read more

Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation
Mangosteen Effects on Inflammatory Markers in Atrial Fibrillation Trial is a study designed to test the primary hypothesis that a dietary supplement (Mangosteen) containing anti-inflammatory and anti-oxidant properties may effect the measured levels of inflammatory biomarkers.
Read more

WATCHMAN Left Atrial Appendage Filter System for Embolic PROTECTion in Patients with Atrial Fibrillation (PROTECT AF)
This study is being done to find out what effects the WATCHMAN Left Atrial Appendage System has on you and your heart and to assess the safety and effectiveness of the device compared to patients who receive blood thinning medication called warfarin (or Coumadin).
Read more

  • Print

Find Mayo Clinic on


Terms of Use and Information Applicable to this Site
Copyright ©2001-2012 Mayo Foundation for Medical Education and Research. All Rights Reserved.

.